Januduo Tablet 10/100 mg
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kims Pharmaceutical Co., Ltd.
MFDS item code 202300386 · Approved 2023.01.30
Improvement in blood glucose control for type 2 diabetes
This medication is used to help control blood glucose levels in patients with type 2 diabetes by combining sitagliptin and dapagliflozin. It supports effective management of blood glucose levels when taken alongside dietary and exercise strategies. Thus, this medication is utilized as a therapeutic agent to aid in the improvement of blood glucose control.
The recommended dosage for this medication is one tablet daily, taken without regard to meals, for patients receiving sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole.
This medication can rarely cause serious allergic reactions, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, you should stop taking it immediately and consult a doctor. This medication carries a risk of pancreatitis, inflammation of the pancreas, so if severe abdominal pain, vomiting, or fever develops, promptly inform a healthcare professional. This medication is not to be used in patients with allergies to specific components, type 1 diabetes, diabetic ketoacidosis, or those undergoing dialysis. It should be used cautiously in patients with reduced fluid volume or impaired kidney function, as there could be a risk of blood pressure drops or worsening kidney function requiring regular monitoring. This medication may cause hypoglycemia, so especially when taken with insulin or sulfonylurea medications, careful monitoring of blood glucose levels may be necessary and dose adjustments may be needed. There may be an increased risk of genital infections or urinary tract infections, so if symptoms of infection arise, immediate treatment should be sought, particularly in patients with a history of infections. This medication is not recommended for use in pregnant or breastfeeding women, and should be discontinued if pregnancy is confirmed. In elderly patients, there may be reduced kidney function, making dose adjustments and monitoring of kidney function vital, along with careful attention to fluid volume and low blood pressure. There is no specific antidote for overdose, so appropriate treatment based on symptoms should be received, and dialysis may be considered if needed. While taking this medication, caution is advised when driving or operating machinery due to the risk of hypoglycemia. This medication should be stored in its original container and kept in a secure place out of the reach of children.
Urticaria, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reaction, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin adverse reactions, difficulty or shortness of breath, asthma attacks, respiratory abnormalities accompanied by cough and fever, respiratory problems, yellowing of skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air and moisture, and it is important to keep it at room temperature between 1°C and 30°C. Storing it this way helps maintain the medication's effectiveness and safety.
Beige oval film-coated tablet
30 tablets/PTP [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kims Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.